Premium
Salivary calcium concentration as a screening tool for postmenopausal osteoporosis
Author(s) -
Rabiei Maryam,
Masooleh Irandokht Shenavar,
Leyli Ehsan Kazemnejad,
Nikoukar Laia Rahbar
Publication year - 2013
Publication title -
international journal of rheumatic diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.795
H-Index - 41
eISSN - 1756-185X
pISSN - 1756-1841
DOI - 10.1111/1756-185x.12003
Subject(s) - osteoporosis , medicine , receiver operating characteristic , bone mineral , calcium , area under the curve , postmenopausal women , area under curve , predictive value , likelihood ratios in diagnostic testing , gastroenterology , urology , dentistry , pharmacokinetics
Aim Measurements of salivary calcium level may be a useful screening tool for osteoporosis in postmenopausal women. The purpose of this study was to clarify whether this measure is valid compared with dual‐energy X ‐ray (Bone Mineral Density) screening tools in osteoporosis. Methods A case‐control study was carried out in 40 postmenopausal women with osteoporosis ( T ‐score ≤ −2.5) and 40 women without osteoporosis ( T ‐score > −1 bone mineral density). Salivary samples were collected and calcium concentrations were measured and expressed as mg/d L . Receiver operating characteristic curve analyses was used to determine the optimal cut‐off thresholds for salivary calcium in healthy postmenopausal women. Results The cut‐off point for salivary calcium was 6.1 mg/d L . The sensitivity and specificity, respectively, for identifying women with osteoporosis, were 67.5 (95% CI 52.33–82.67) and 60% (95% CI 44.62–75.38). The area under curve ( AUC ) was 0.678 (95% CI 0.56–0.79), the positive predictive value ( PPV ) was 62.79 (95% CI 47.74–77.84) and negative predictive value ( NPV ) was 64.86% (95% CI 49.27–80.46). The positive likelihood ratio was 1.688 and the negative likelihood ratio was 0.542. Conclusions Salivary calcium concentration discriminates between women with and without osteoporosis and constitutes a useful tool for screening for osteoporosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom